Behavioral Neuroscience – Products
Study Finds Chatbot Reduced Problematic Substance Use During Pandemic
Woebot Health has announced that the Journal of Medical Internet Research (JMIR), has published the results of its latest study. The study is one of the first to explore substance use disorder interventions via mobile apps.
Havn Life Sciences To Supply Psychedelics to Clinical Studies Focused on Veterans and PTSD
Havn Life Sciences Inc. a biotechnology company, announced it has signed a Memorandum of Agreement (“MOA”) with the international veterans organization, Heroic Hearts Project.
BioMed X Institute Completes First Research Project in Neuroscience
BioMed X announces the successful completion of its first joint research project with Boehringer Ingelheim in neuroscience.
WeWALK Joins Microsoft's AI for Accessibility Programme
WeWALK has joined Microsoft’s AI for Accessibility programme to accelerate WeWALK’s capability by developing and validating a human behaviour model and creating a Voice Assistant for visually impaired users, providing the right mobility information when needed and allowing for even greater control of the WeWALK mobility experience.
Separation and Characterization of Viruses and Antibodies
Postnova Analytics has published a new white paper that details how multi-detector Asymmetrical Field Flow Fractionation (AF4) and Electrical AF4 (EAF4) techniques are transforming the separation and characterization of viruses and antibodies.
Lyndra Therapeutics Files IND, Adds to Leadership Team and Readies for Manufacturing
Lyndra Therapeutics has filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for its ultra-long-acting oral therapy to treat schizophrenia (risperidone).
BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim
BioMed X is collaborating with Boehringer Ingelheim to investigate myelination deficits of the adolescent brain in connection with the development of schizophrenia.
Emotion Recognition AI, M Unveiled at Conference, Rivaling Industry Leaders in Accuracy
It is hoped that AI screening of human emotions will eventually help eliminate mental diseases and depression.
Leveraging ZEISS Airyscan to Integrate subcellular and Structural Detail with Inscopix Functional Neural Network Data
Expanding freely behaving microscopy by delivering increased resolution, signal-to-noise and optical sectioning through data correlation.
fNIRS System for Brain Imaging Research